<DOC>
	<DOC>NCT02634034</DOC>
	<brief_summary>The purpose of this study is to compare the pharmacokinetics and safety of a controlled release (CR) version of pitavastatin (also referred to as NK-104) to immediate release (IR) pitavastatin in healthy adult volunteers.</brief_summary>
	<brief_title>A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Subject provides written informed consent before any studyspecific evaluation is performed. Subject is a healthy adult male or female volunteer between the ages of 18 and 45 years, inclusive. Subject has no clinically significant abnormalities on the basis of medical history, physical examination findings, or vital sign measurements, as judged by the Investigator. Subject is able and willing to comply with the protocol and study procedures. Subject is a woman who is pregnant or breastfeeding. Subject has clinically relevant abnormalities in the screening or checkin assessments. Subject has received an investigational drug within 30 days before the first dose of study drug.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>